Chirurgische Aspekte der Behandlung des Prostatakarzinoms

In der vorliegenden Arbeit wird die chirurgische Therapie des Prostatakarzinoms erläutert. Im primären Therapiesetting wird die radikale Prostatektomie diskutiert, welche mit oder ohne pelviner Lymphadenektomie angeboten werden kann. Die modernen Entwicklungen hinsichtlich anatomischer Dissektionsmethoden mit intraoperativer Schnellschnittdiagnostik sowie die Unterschiede der („offenen“) retropubischen gegenüber der minimalinvasiven, Roboter-assistierten radikalen Prostatektomie werden aufgezeigt. Schließlich wird die Indikation für die Salvage-Prostatektomie, aber auch die Salvage-Lymphadenektomie im Rezidivfall besprochen, welche beide idealerweise im Rahmen von prospektiven Studien und in hochspezialisierten Zentren angeboten werden sollten.

Schlüsselwörter

Behandlung - Prostatakarzinom - chirurgische Aspekte - Chirurgie

Publication History

Article published online:
04 October 2022

• Literatur

• 1 Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF. Leitlinienprogramm Onkologie: S3-Leitlinie Prostatakarzinom, Langversion, AWMF Registernummer: 043/022OL. Accessed February 06, 2021 at: http://www.leitlinienprogramm-onkologie.de/leitlinien/prostatakarzinom/
• 2 Bill-Axelson A, Holmberg L, Garmo H. et al. Radical Prostatectomy or Watchful Waiting in Prostate Cancer — 29-Year Follow-up. N Engl J Med 2018; 379: 2319-2329
• 3 Mottet N, van den Bergh RCN, Briers E. et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2021; 79: 243-262
• 4 Schlomm T, Tennstedt P, Huxhold C. et al. Neurovascular Structure-adjacent Frozen-section Examination (NeuroSAFE) Increases Nerve-sparing Frequency and Reduces Positive Surgical Margins in Open and Robot-assisted Laparoscopic Radical Prostatectomy: Experience After 11 069 Consecutive Patients. Eur Urol 2012; 62: 333-340
• 5 Schlomm T, Heinzer H, Steuber T. et al. Full Functional-Length Urethral Sphincter Preservation During Radical Prostatectomy. Eur Urol 2011; 60: 320-329
• 6 Moris L, Cumberbatch MG, Van den Broeck T. et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020; 77: 614-627
• 7 Parker CC, James ND, Brawley CD. et al. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Lancet 2018; 392: 2353-2366
• 8 Coughlin GD, Yaxley JW, Chambers SK. et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. Lancet Oncol 2018; 19: 1051-1060
• 9 Haese A, Knipper S, Isbarn H. et al. A comparative study of robot-assisted and open radical prostatectomy in 10 790 men treated by highly trained surgeons for both procedures. BJU Int 2019; 123: 1031-1040
• 10 Würnschimmel C, Graefen M. Orphaned Side-effects After Robot-assisted Radical Prostatectomy: Is the Retzius-sparing Approach Superior to the Standard Approach or Are the Data Just Not Mature Enough?. Eur Urol Open Sci 2021; 23: 34-35
• 11 Rosenberg JE, Jung JH, Edgerton Z. et al. Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer. Cochrane Database Syst Rev 2020;
• 12 Checcucci E, De Cillis S, Pecoraro A. et al. Single-port robot-assisted radical prostatectomy: a systematic review and pooled analysis of the preliminary experiences. BJU Int 2020; 126: 55-64
• 13 Mullins JK, Feng Z, Trock BJ. et al. The Impact of Anatomical Radical Retropubic Prostatectomy on Cancer Control: The 30-Year Anniversary. J Urol 2012; 188: 2219-2224
• 14 Würnschimmel C, Wenzel M, Wang N. Radical prostatectomy for localized prostate cancer: 20-year oncological outcomes from a German high-volume center. Urol Oncol Semin Orig Investig 2021;
• 15 Schlomm T, Tennstedt P, Huxhold C. et al. Neurovascular Structure-adjacent Frozen-section Examination (NeuroSAFE) Increases Nerve-sparing Frequency and Reduces Positive Surgical Margins in Open and Robot-assisted Laparoscopic Radical Prostatectomy: Experience After 11 069 Consecutive Patients. Eur Urol 2012; 62: 333-340
• 16 Develtere D, Rosiello G, Piazza P. et al. Early Catheter Removal on Postoperative Day 2 After Robot-assisted Radical Prostatectomy: Updated Real-life Experience with the Aalst Technique. Eur Urol Focus 2021;
• 17 Briganti A, Chun FKH, Salonia A. et al. Complications and Other Surgical Outcomes Associated with Extended Pelvic Lymphadenectomy in Men with Localized Prostate Cancer. Eur Urol 2006; 50: 1006-1013
• 18 Pompe RS, Beyer B, Haese A. et al. Postoperative complications of contemporary open and robot-assisted laparoscopic radical prostatectomy using standardised reporting systems. BJU Int 2018; 122: 801-807
• 19 Mandel P, Steuber T, Ahyai S. et al. Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria. BJU Int 2016; 117: 55-61
• 20 Nathan A, Fricker M, De Groote R. et al. Salvage Versus Primary Robot-assisted Radical Prostatectomy: A Propensity-matched Comparative Effectiveness Study from a High-volume Tertiary Centre. Eur Urol Open Sci 2021; 27: 43-52
• 21 Horn T, Krönke M, Rauscher I. et al. Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Rec. Eur Urol 2019; 76: 517-523